Search Results - "Longbrake EE"

Diagnostic performance of central vein sign and paramagnetic rim lesion integration for multiple sclerosis.

Authors: Toljan K Renner B Daboul L et al.

Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2026 May; Vol. 32 (6), pp. 614-623. Date of Electronic Publication: 2026 Apr 20.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

Differential results of genetic risk scoring for multiple sclerosis in European and African American populations.

Authors: Rivier CA Xu L Clocchiatti-Tuozzo S et al.

Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2025 Oct; Vol. 31 (11), pp. 1304-1313. Date of Electronic Publication: 2025 Sep 24.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

Evaluation of the relationship between brainstem lesions and apnea hypopnea index in patients with multiple sclerosis.

Authors: Levit E Cohen I Mahajan A et al.

Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2025 Jun; Vol. 31 (7), pp. 802-812. Date of Electronic Publication: 2025 Mar 29.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

Patient and Physician Perspectives of Treatment Burden in Multiple Sclerosis.

Authors: Singer, Barry A. Morgan, Dawn Stamm, Julie A. et al.

Source: Neurology & Therapy. Dec2024, Vol. 13 Issue 6, p1507-1525. 19p.

SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study.

Authors: Chia PHJ Toyonaga T Tong J et al.

Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2026 Mar 10; Vol. 123 (10), pp. e2517709123. Date of Electronic Publication: 2026 Mar 03.

Publication Type: Journal Article

Journal Info: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

Managing Relapsing Multiple Sclerosis Across the Lifespan: A Narrative Review with Expert Opinion from Norway.

Authors: Simonsen, Cecilia Smith König, Marton Bjelland, Stein Henry et al.

Source: Neurology & Therapy. Jun2026, Vol. 15 Issue 3, p907-923. 17p.

A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis.

Authors: Iaffaldano, Pietro Lucisano, Giuseppe Guerra, Tommaso et al.

Source: Annals of Clinical & Translational Neurology. Aug2024, Vol. 11 Issue 8, p2008-2015. 8p.

Anti CD20 induced hypogammaglobulinemia in multiple sclerosis and neuromyelitis optica spectrum disorder: a cross sectional study.

Authors: ElGarhy, Ibrahim Nassef, Ayman Mohamed Ahmed Fouad, Mohamed Mahmoud et al.

Source: Egyptian Journal of Neurology, Psychiatry & Neurosurgery. 3/25/2026, Vol. 62 Issue 1, p1-7. 7p.

Advancing Care in Myasthenia Gravis: What Can We Learn From the Multiple Sclerosis Community?

Authors: Howard Jr., James F. Sadeghian, Mona Savic, Natasa et al.

Source: Neurology & Therapy. Feb2026, Vol. 15 Issue 1, p1-14. 14p.

Role of Immune Reconstitution Therapy with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in Older Patients.

Authors: Alroughani, Raed Inshasi, Jihad Farouk, Samar et al.

Source: Neurology & Therapy. Aug2025, Vol. 14 Issue 4, p1169-1184. 16p.

Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosis.

Authors: Toljan K Daboul L Raza P et al.

Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Sep; Vol. 30 (10), pp. 1268-1277. Date of Electronic Publication: 2024 Sep 05.

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

Choroid plexus volume differentiates MS from its mimics.

Authors: Levit E Ren Z Gonzenbach V et al.

Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Jul; Vol. 30 (8), pp. 1072-1076. Date of Electronic Publication: 2024 Mar 13.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Naïve Patients and Switchers in a Multicenter Cohort.

Authors: Mangialardi V Macchitella G Vitobello R et al.

Source: Drugs - real world outcomes [Drugs Real World Outcomes] 2026 Jun; Vol. 13 (2), pp. 279-287. Date of Electronic Publication: 2026 May 31.

Publication Type: Journal Article

Journal Info: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101658456 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2199-1154 (Print) Linking ISSN: 21989788 NLM ISO Abbreviation: Drugs Real World Outcomes Subsets: PubMed not MEDLINE

Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial.

Authors: Haidar G Thomas S Loubet P et al.

Corporate Authors: Haidar G Thomas S Loubet P et al.

Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2025 Jul; Vol. 25 (7), pp. 813-826. Date of Electronic Publication: 2025 Feb 24.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study

Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE

Dietary composition modulate gut microbiota and related biomarkers in patients with chronic kidney disease.

Authors: Udomkarnjananun, Suwasin Chuaypen, Natthaya Metta, Kamonchanok et al.

Source: Scientific Reports. 10/16/2025, Vol. 15 Issue 1, p1-13. 13p.

Bariatric surgery and dimethyl fumarate-induced lymphopenia in patients with multiple sclerosis.

Authors: Andreozzi, Valentina Capuano, Rocco Scannapieco, Sara et al.

Source: Neurological Sciences. Jun2024, Vol. 45 Issue 6, p2807-2810. 4p.

Subjects: Lymphocyte count, Bariatric surgery, Lymphopenia, Multiple sclerosis, Dimethyl fumarate, Body mass index

A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis.

Authors: Daboul L O'Donnell CM Amin M et al.

Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Jan; Vol. 30 (1), pp. 25-34. Date of Electronic Publication: 2023 Dec 13.

Publication Type: Multicenter Study; Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

Impact of Anti-CD20 Therapies on Cytokine, Chemokine and Adhesion Molecule Dynamics in Multiple Sclerosis: A Narrative Review.

Authors: Messner, Marc Mitterwallner, Josef-Martin Unterhofer, Michael et al.

Source: Neurology & Therapy. Jun2026, Vol. 15 Issue 3, p863-886. 24p.

Administration and Monitoring Burden of High-Efficacy Disease-Modifying Therapies for Multiple Sclerosis: A Delphi Consensus of Clinical Experts from Saudi Arabia.

Authors: Makkawi, Seraj Abulaban, Ahmad Al Malik, Yaser et al.

Source: Neurology & Therapy. Feb2025, Vol. 14 Issue 1, p413-427. 15p.

No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review].

Authors: Newsome, Scott D. Binns, Cherie Kaunzner, Ulrike W. et al.

Source: Neurology & Therapy. Dec2023, Vol. 12 Issue 6, p1909-1935. 27p.